FilingSEC EDGAR6-K
Kazia Therapeutics Changes ADR Depositary to JPMorgan
· SEC accepted
StageOperational Change
Filing content
Kazia Therapeutics appointed JPMorgan as the sole depositary for its ADR program, replacing BNY Mellon, with no action required from existing ADS holders.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…